azacitidine and Carcinoma, Anaplastic

azacitidine has been researched along with Carcinoma, Anaplastic in 74 studies

Research

Studies (74)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (2.70)	18.7374
1990's	5 (6.76)	18.2507
2000's	33 (44.59)	29.6817
2010's	32 (43.24)	24.3611
2020's	2 (2.70)	2.80

Authors

Authors	Studies
Athwal, RS; Kandpal, RP; Zhawar, VK	1
Wang, Y; Zhu, P	1
Liu, J; Liu, W; Luo, B; Wang, J; Zhao, Z	1
Bendinelli, P; Desiderio, MA; Locatelli, A; Maroni, P; Matteucci, E	1
Bultmann, I; Conradi, A; Kretschmer, C; Sterner-Kock, A	1
Hinoda, Y; Morishige, A; Nakamura, M; Nishikawa, J; Oga, A; Okada, T; Saito, M; Sakai, K; Sakaida, I; Sasaki, K; Suehiro, Y; Zhang, Y	1
Gong, P; Li, J; Li, X; Lyu, X; Peng, H; Yao, K	1
Chen, M; Fan, H; Feng, K; Fu, X; Guo, B; Han, W; Liu, Y; Lu, X; Nie, J; Shi, F; Wang, X; Wang, Y; Zhang, W; Zhang, Y; Zhu, H	1
Allaya, N; Ayadi, W; Daoud, J; Frikha, H; Frikha, M; Gargouri, A; Ghorbel, A; Khabir, A; Mokdad-Gargouri, R; Trigui, E	1
Claret, FX; Wang, S; Yang, H; Zhang, R	1
Liu, ZH; Luo, FY; Tang, CE; Xiao, S; Xiao, ZQ; Zhang, PF	1
Almgren, M; Du, ZM; Ernberg, I; Hu, LF; Ignatyev, I; Kashuba, V; Moumad, K; Nawaz, I; Pavlova, TV; Zabarovsky, ER	1
Borikun, TV; Burlaka, AP; Chekhun, VF; Demash, DV; Lozovska, YV; Lukianova, NY; Naleskina, LA; Pavlova, AO; Storchay, DM; Todor, IN; Yalovenko, TM; Zadvornyi, TV	1
Ahuja, N; Baylin, SB; Costello, JF; Easwaran, H; Eberhart, CG; Glöckner, SC; Herman, JG; James, CD; Laterra, J; Lin, S; Ohm, JE; Riggins, G; Schuebel, KE; Tsai, HC; Vescovi, AL; Yi, JM	1
Agate, L; Capodanno, A; Ciampi, R; Collecchi, P; Elisei, R; Miasaki, FY; Pinchera, A; Vivaldi, A	1
Krynetskaia, NF; Krynetskiy, E; Mishra, AK; Phadke, MS	1
Bazarov, AV; Hines, WC; Mukhopadhyay, R; Yaswen, P	1
Egan, LJ; Foran, E; Garrity-Park, MM; Limburg, PJ; Mureau, C; Newell, J; Smyrk, TC	1
Chan, JY; Ho, WK; Man, OY; To, VS; Tsang, CM; Tsang, RK; Tsao, SW; Wei, WI; Wong, TS	1
Arvia, R; Deledda, C; Gelmini, S; Luciani, P; Malentacchi, F; Mannelli, M; Orlando, C; Peri, A; Simi, L	1
Higashi, M; Houjou, I; Kitamoto, S; Yamada, N; Yokoyama, S; Yonezawa, S	1
Chan, AW; Chan, MW; Chau, SL; Lee, TL; Leung, PP; Lo, KW; Lung, RW; Ng, DC; So, KK; To, KF; Tong, JH	1
Du, C; Huang, G; Huang, T; Lin, L; Ma, N; Mo, Y; Murata, M; Wang, S; Xiao, X; Yu, N; Zhang, J; Zhang, Z; Zhou, X	1
Gamo, T; Habano, W; Otsuka, K; Ozawa, S; Sugai, T; Terashima, J; Wakabayashi, G	1
Feng, L; Wu, Y; Xie, Y; Zhang, H	1
Dong, X; Korch, C; Meinkoth, JL	1
Hayashi, Y; Imai, T; Kikumori, T; Kiuchi, T; Kurebayashi, J; Murata, Y; Sassa, M; Watanabe, R	1
Becker, K; Hapfelmeier, A; Höfler, H; Keller, G; Langer, R; Mutze, K; Novotny, A; Ott, K; Schumacher, F	1
Auersperg, N; Cheng, JC; Leung, PC	1
Akerström, G; Björklund, P; Carling, T; Dralle, H; Lifton, RP; Starker, LF; Svedlund, J; Udelsman, R; Westin, G	1
Guo, J; Guo, L; Han, X; Li, J; Qu, Q; Sun, HD; Tan, WH; Yi, TZ	1
Cho, BN; Cho, C; Kim, BH; Kim, YI; Lee, HK; Lee, SJ; Shim, J	1
Chen, R; Hu, Q; Ji, L; Liao, QP; Wang, YL; Xie, Y; Yu, L; Zhang, Y	1
Chan, SH; Chen, H; Cheung, FM; Chiu, PM; Chua, D; Hyytiainen, M; Kan, R; Keski-Oja, J; Ko, JM; Kwong, DL; Lee, AW; Lung, ML; Nicholls, JM; Stanbridge, EJ; Tao, Q; Tsao, SW; Wong, VC; Zabarovsky, ER	1
He, G; Li, H; Li, W; Ma, Y; Tan, G; Zhang, X	1
Andry, G; De Martelar, V; Dom, G; Dumont, JE; Galdo, VC; Hébrant, A; Leteurtre, E; Libert, F; Maenhaut, C; Tarabichi, M; Tomás, G; van Staveren, WC	1
Byun, DW; Chun, SW; Jung, CH; Kang, SG; Kim, BY; Kim, CH; Kim, SJ; Kim, YJ; Ko, HJ; Mok, JO; Park, HK; Suh, KI; Yoo, MH	1
Chan, A; Chang, HW; Kwong, DL; Sham, JS; Wei, WI; Yuen, AP	1
Chen, HK; Feng, QS; Li, A; Liu, XQ; Long, QX; Pan, ZG; Wang, XZ; Zeng, YX; Zhang, XS	1
Benoit, NE; Dong, SM; Kuzmin, I; Lerman, MI; Sidransky, D; Sun, DI	1
Chayama, K; Ito, R; Kitadai, Y; Nakayama, H; Oshimo, Y; Yasui, W; Yoshida, K	1
Anderton, JA; Bailey, S; Clifford, SC; Ellison, DW; Gilbertson, RJ; Lindsey, JC; Lusher, ME; Pearson, AD	1
Akiyama, Y; Fujisawa, K; Honda, T; Ishida, K; Itabashi, T; Maesawa, C; Masuda, T; Noda, Y; Saito, K; Sato, N; Takagane, A; Wada, K	1
Lim, CY; Loh, KS; Qiu, GH; Srivastava, G; Tan, LK; Tao, Q; Tsai, ST; Tsao, SW	1
Butcher, DT; Haines, TR; Rodenhiser, DI; Sadikovic, B	1
Bilchik, AJ; Fujimoto, A; Hoon, DS; Shinozaki, M; Takeuchi, H; Umetani, N	1
Biesová, Z; Jakubicková, L; Kettmann, R; Pastorek, J; Pastoreková, S	1
Bae, SI; Jee, CD; Kim, WH; Lee, HS; Lee, YM; Rho, MS; Yang, HK	1
End-Pfützenreuter, A; Fong, KM; Gazdar, AF; Girard, L; Heller, G; Lang, G; Minna, JD; Seidl, S; Zielinski, CC; Zöchbauer-Müller, S	1
Chan, AT; Langford, C; Li, H; Murray, P; Putti, T; Seng, TJ; Srivastava, G; Tao, Q; Tsao, SW; Ying, J	1
Chen, JK; Chou, J; He, B; Jablons, DM; Kim, J; Kuchenbecker, K; Lin, YC; Mikami, I; Raz, D; Thung, E; Xu, Z; Yang, CT; You, L	1
Chen, H; Costa, M; Ke, Q; Kluz, T; Yan, Y	1
Domann, FE; Howe, JR; Lal, G; Nicholson, RM; O'Dorisio, MS; Padmanabha, L; Smith, BJ	1
Berger, W; Depisch, D; Filipits, M; Geradts, J; Heller, G; Kandioler, D; Markis-Ritzinger, EM; Newsham, I; Pirker, R; Stiglbauer, W; Ziegler, B; Zielinski, CC; Zöchbauer-Müller, S	1
Chan, AT; Chan, SL; Cui, Y; Jin, H; Lee, KY; Li, H; Ng, KM; Rha, SY; Robertson, KD; Srivastava, G; Tao, Q; Tsao, GS; van Hasselt, A; Wang, Y; Zhong, S	1
Li, H; Peng, D; Ren, CP; Wang, L; Yao, KT; Yi, HM; Zhang, HJ; Zhao, M	1
Baek, JH; Chang, X; Dasgupta, S; Kim, MS; Moon, C; Nagpal, JK; Osada, M; Ratovitski, EA; Sidransky, D; Trink, B; Westra, WH; Woo, JH; Wu, G; Yamashita, K	1
Fukuyoshi, Y; Inoue, H; Ishii, H; Kita, Y; Mimori, K; Mori, M; Motoyama, K; Ohta, M; Yamashita, K	1
Ethier, SP; Hanifi-Moghaddam, P; Hollestelle, A; Klijn, JG; Merajver, SD; Schutte, M; van den Ouweland, A; Wasielewski, M	1
Cortese, R; de Leij, LFMH; Jeltsch, A; Kiss, A; McLaughlin, PMJ; Monami, A; Raskó, T; Rots, MG; Ruiters, MHJ; Ślaska-Kiss, K; van der Gun, BTF; Wasserkort, R; Weinhold, E	1
Chahinian, AP; Greenfield, DS; Holland, JF; Ohnuma, T	1
Hirohashi, S; Kanai, Y; Ochiai, A; Shimoyama, Y; Sugimura, T; Yoshiura, K	1
Chae, HS; Chen, A; Deng, G; Hong, J; Kim, YS	1
Bang, YJ; Choi, HH; Inoue, H; Jong, HS; Kim, NK; Song, SH; Tanabe, T	1
Ito, R; Kuniyasu, H; Kuraoka, K; Oue, N; Shigeishi, H; Yasui, W; Yokozaki, H	1
Cheung, AL; Lam, KY; Liu, Y; Shen, ZY; Si, HX; Srivastava, G; Tsao, SW; Wong, YC	1
Crichton, DN; Hupp, TR; Kernohan, N; McDowell, HE; Nicoll, G; Thompson, AM	1
Biesta, P; Quinten, E; van den Elsen, PJ; van der Stoep, N	1
Dallol, A; Forgacs, E; Kishida, T; Latif, F; Maher, ER; Martinez, A; Minna, JD; Rabbitts, P; Sekido, Y; Walker, R	1
Bae, SI; Kim, SH; Kim, WH; Lee, HS	1
Abbruzzese, JL; Ajani, JA; Daugherty, K; Hubbard, KP; Levin, B; Pazdur, R	1
Esparza, L; Holmes, FA; Hortobagyi, GN; Theriault, RL; Walters, RS	1
Cavalli, F; Renard, J; Sessa, C; Stoter, G; ten Bokkel Huinink, W	1
Takenaga, K	1

Reviews

1 review(s) available for azacitidine and Carcinoma, Anaplastic

Article	Year
Modification of the metastatic potential of tumor cells by drugs. Cancer metastasis reviews, 1986, Volume: 5, Issue:2 Topics: Animals; Azacitidine; Butyrates; Butyric Acid; Carcinoma; Cell Division; Cell Line; Cells, Cultured; Dimethyl Sulfoxide; Lung Neoplasms; Mice; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplastic Cells, Circulating; Phenotype	1986

Trials

3 trial(s) available for azacitidine and Carcinoma, Anaplastic

Article	Year
Low-dose decitabine-based chemoimmunotherapy for patients with refractory advanced solid tumors: a phase I/II report. Journal of immunology research, 2014, Volume: 2014 Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Carcinoma; Combined Modality Therapy; Cyclophosphamide; Decitabine; DNA Methylation; DNA Modification Methylases; Double-Blind Method; Doxorubicin; Female; Humans; Immunotherapy; Killer Cells, Natural; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms; Prednisone; Prospective Studies; Survival Analysis; Vincristine	2014
Phase II trial of fazarabine in advanced colorectal carcinoma. Investigational new drugs, 1992, Volume: 10, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Azacitidine; Carcinoma; Colorectal Neoplasms; Drug Administration Schedule; Drug Evaluation; Humans; Male; Middle Aged	1992
Phase II trial of fazarabine (ARA-AC, arabinosyl-5-azacytosine) in metastatic breast cancer. Investigational new drugs, 1992, Volume: 10, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Azacitidine; Breast Neoplasms; Carcinoma; Drug Evaluation; Female; Humans; Middle Aged	1992

Other Studies

70 other study(ies) available for azacitidine and Carcinoma, Anaplastic

Article	Year
Alternative Promoters of Genes, 2022, 03-10, Volume: 13, Issue:3 Topics: Azacitidine; Carcinoma; Cell Line, Tumor; CpG Islands; DNA Methylation; Humans; Luciferases	2022
Multiple keratoacanthomas in a patient with myelodysplastic syndrome. The Lancet. Haematology, 2021, Volume: 8, Issue:1 Topics: Aclarubicin; Administration, Topical; Antineoplastic Agents; Azacitidine; Carcinoma; Female; Humans; Imiquimod; Keratoacanthoma; Middle Aged; Myelodysplastic Syndromes	2021
The effect of EBV on WIF1, NLK, and APC gene methylation and expression in gastric carcinoma and nasopharyngeal cancer. Journal of medical virology, 2017, Volume: 89, Issue:10 Topics: Adaptor Proteins, Signal Transducing; Azacitidine; Carcinoma; Cell Line, Tumor; Cell Movement; Cell Proliferation; DNA Methylation; Genes, APC; Herpesvirus 4, Human; Humans; Intracellular Signaling Peptides and Proteins; MicroRNAs; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Promoter Regions, Genetic; Protein Serine-Threonine Kinases; Repressor Proteins; Stomach Neoplasms	2017
Epigenetic control of endothelin-1 axis affects invasiveness of breast carcinoma cells with bone tropism. Experimental cell research, 2013, Jul-15, Volume: 319, Issue:12 Topics: Azacitidine; Bone Neoplasms; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Cell Movement; Collagen; Dactinomycin; DNA Methylation; Drug Combinations; Endothelin A Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Laminin; Mutation; Neoplasm Invasiveness; Peptides, Cyclic; Proteoglycans; Proto-Oncogene Protein c-ets-1; Receptor, Endothelin A; RNA Stability; RNA, Messenger; Transcription, Genetic	2013
Latent transforming growth factor β-binding protein 4 is downregulated in esophageal cancer via promoter methylation. PloS one, 2013, Volume: 8, Issue:5 Topics: Azacitidine; Base Sequence; Binding Sites; Carcinoma; Cell Line, Tumor; Cell Movement; Decitabine; Disease Progression; DNA Methylation; Down-Regulation; Esophageal Neoplasms; Gene Expression Regulation, Neoplastic; Gene Order; Humans; Latent TGF-beta Binding Proteins; Neoplasm Staging; Promoter Regions, Genetic; Protein Binding; Transcription Factors; Transforming Growth Factor beta1	2013
Identification of genes specifically methylated in Epstein-Barr virus-associated gastric carcinomas. Cancer science, 2013, Volume: 104, Issue:10 Topics: Aged; Azacitidine; Carcinoma; Cell Line, Tumor; Cytoskeletal Proteins; Decitabine; DNA Methylation; DNA-Binding Proteins; DNA, Neoplasm; Epstein-Barr Virus Infections; Female; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Homeodomain Proteins; Humans; Hydroxamic Acids; Male; Microfilament Proteins; Middle Aged; Neoplasm Proteins; Nerve Tissue Proteins; Nuclear Proteins; Oncogene Proteins; Promoter Regions, Genetic; Protein Serine-Threonine Kinases; Real-Time Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Stomach Neoplasms; Transcription Factors; Tumor Protein p73; Tumor Suppressor Proteins	2013
Aberrant CpG island methylation of PTEN is an early event in nasopharyngeal carcinoma and a potential diagnostic biomarker. Oncology reports, 2014, Volume: 31, Issue:5 Topics: Azacitidine; Base Sequence; Biomarkers, Tumor; Carcinoma; Cell Line, Tumor; CpG Islands; Decitabine; DNA Methylation; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Mutation; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Promoter Regions, Genetic; PTEN Phosphohydrolase; RNA, Messenger; Sequence Analysis, DNA	2014
Identification of a novel methylated gene in nasopharyngeal carcinoma: TTC40. BioMed research international, 2014, Volume: 2014 Topics: Animals; Azacitidine; Carcinoma; Cell Line, Tumor; CpG Islands; Cytoskeletal Proteins; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; High-Throughput Nucleotide Sequencing; Humans; Mice; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Proteins; Promoter Regions, Genetic; Proteins; Xenograft Model Antitumor Assays	2014
Involvement of microRNA-24 and DNA methylation in resistance of nasopharyngeal carcinoma to ionizing radiation. Molecular cancer therapeutics, 2014, Volume: 13, Issue:12 Topics: Animals; Azacitidine; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cluster Analysis; Decitabine; Disease Models, Animal; DNA Methylation; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Histones; Humans; Male; Mice; MicroRNAs; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Radiation Tolerance; Radiation, Ionizing; Tumor Burden; Xenograft Model Antitumor Assays	2014
Kank1 reexpression induced by 5-Aza-2'-deoxycytidine suppresses nasopharyngeal carcinoma cell proliferation and promotes apoptosis. International journal of clinical and experimental pathology, 2015, Volume: 8, Issue:2 Topics: Adaptor Proteins, Signal Transducing; Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; Blotting, Western; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cytoskeletal Proteins; Decitabine; DNA Methylation; Gene Expression Regulation, Neoplastic; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Real-Time Polymerase Chain Reaction; Tumor Suppressor Proteins	2015
Integrin α9 gene promoter is hypermethylated and downregulated in nasopharyngeal carcinoma. Oncotarget, 2015, Oct-13, Volume: 6, Issue:31 Topics: Antimetabolites, Antineoplastic; Azacitidine; Blotting, Western; Carcinoma; Case-Control Studies; Cell Proliferation; Cells, Cultured; Decitabine; DNA Methylation; Gene Expression Regulation, Neoplastic; Humans; Integrin alpha Chains; Integrins; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Nasopharynx; Promoter Regions, Genetic; Real-Time Polymerase Chain Reaction; Wnt Proteins	2015
Modifying effects of 5-azacytidine on metal-containing proteins profile in Guerin carcinoma with different sensitivity to cytostatics. Experimental oncology, 2016, Volume: 38, Issue:4 Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Carcinoma; Cytostatic Agents; DNA Methylation; Epigenesis, Genetic; Female; Gene Expression Profiling; Metalloproteins; Promoter Regions, Genetic; Proteome; Proteomics; Rats	2016
Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors. Cancer research, 2008, Oct-01, Volume: 68, Issue:19 Topics: AC133 Antigen; Animals; Antigens, CD; Antineoplastic Agents; Azacitidine; Brain Neoplasms; Caco-2 Cells; Carcinoma; Colorectal Neoplasms; Decitabine; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Female; Gene Deletion; Gene Expression Regulation, Neoplastic; Glioblastoma; Glycoproteins; HCT116 Cells; HT29 Cells; Humans; Mice; Mice, Nude; Peptides; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2008
Retinoic acid receptor beta2 re-expression and growth inhibition in thyroid carcinoma cell lines after 5-aza-2'-deoxycytidine treatment. Journal of endocrinological investigation, 2008, Volume: 31, Issue:8 Topics: Antimetabolites, Antineoplastic; Azacitidine; Carcinoma; Cell Line, Tumor; Cell Proliferation; Decitabine; DNA Methylation; Gene Expression Regulation, Neoplastic; Humans; Organ Specificity; Promoter Regions, Genetic; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Retinoic Acid Receptor gamma; Thyroid Gland; Thyroid Neoplasms; Transfection	2008
Glyceraldehyde 3-phosphate dehydrogenase depletion induces cell cycle arrest and resistance to antimetabolites in human carcinoma cell lines. The Journal of pharmacology and experimental therapeutics, 2009, Volume: 331, Issue:1 Topics: Antimetabolites, Antineoplastic; Azacitidine; Carcinoma; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Gene Knockdown Techniques; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Lung Neoplasms	2009
BORIS (CTCFL) is not expressed in most human breast cell lines and high grade breast carcinomas. PloS one, 2010, Mar-17, Volume: 5, Issue:3 Topics: Alternative Splicing; Azacitidine; Breast Neoplasms; Carcinoma; CCCTC-Binding Factor; Cell Line, Tumor; Decitabine; DNA-Binding Proteins; Exons; Fibroblasts; Gene Expression Regulation, Neoplastic; Humans; Polymerase Chain Reaction; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tissue Distribution	2010
Upregulation of DNA methyltransferase-mediated gene silencing, anchorage-independent growth, and migration of colon cancer cells by interleukin-6. Molecular cancer research : MCR, 2010, Volume: 8, Issue:4 Topics: Azacitidine; Carcinogenicity Tests; Carcinoma; Cell Line, Tumor; Cell Movement; Cell Transformation, Neoplastic; Colitis; Colonic Neoplasms; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Down-Regulation; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Gene Silencing; Genes, Tumor Suppressor; Humans; Immunohistochemistry; Inflammation Mediators; Interleukin-6; Neoplasm Metastasis; Promoter Regions, Genetic; Up-Regulation	2010
MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression. Journal of cancer research and clinical oncology, 2011, Volume: 137, Issue:3 Topics: Azacitidine; Carcinoma; Cell Growth Processes; Cell Line, Tumor; Cytidine; DNA Methylation; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; MicroRNAs; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Proto-Oncogene Proteins c-myc; Transfection; Up-Regulation	2011
Seladin-1 expression is regulated by promoter methylation in adrenal cancer. BMC cancer, 2010, May-13, Volume: 10 Topics: Adrenal Gland Neoplasms; Azacitidine; Carcinoma; Cell Line, Tumor; Decitabine; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Epigenesis, Genetic; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Nerve Tissue Proteins; Oxidoreductases Acting on CH-CH Group Donors; Polymerase Chain Reaction; Promoter Regions, Genetic; RNA, Messenger; Time Factors	2010
Promoter hypomethylation contributes to the expression of MUC3A in cancer cells. Biochemical and biophysical research communications, 2010, Jun-25, Volume: 397, Issue:2 Topics: 5' Flanking Region; Azacitidine; Carcinoma; Cell Line, Tumor; Decitabine; DNA Methylation; Gene Expression; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Hydroxamic Acids; Mucin-3; RNA, Messenger	2010
Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma. BMC cancer, 2010, Jun-03, Volume: 10 Topics: Adaptor Proteins, Signal Transducing; Adolescent; Adult; Aged; Aged, 80 and over; Animals; Apoptosis Regulatory Proteins; Azacitidine; Carcinoma; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Decitabine; DNA Methylation; DNA Modification Methylases; Down-Regulation; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Genes, Tumor Suppressor; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Immunohistochemistry; Male; Mice; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Transplantation; Polymerase Chain Reaction; Promoter Regions, Genetic; Proto-Oncogene Proteins c-fos; RNA, Messenger; Time Factors; Transfection; Tumor Suppressor Proteins; Young Adult	2010
TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma. BMC cancer, 2010, Nov-09, Volume: 10 Topics: Azacitidine; Carcinoma; Cell Line, Tumor; Cell Proliferation; Decitabine; DNA Methylation; Epigenesis, Genetic; Flow Cytometry; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Glycoproteins; Humans; Nasopharyngeal Neoplasms; Promoter Regions, Genetic; RNA, Messenger	2010
Involvement of promoter methylation in the regulation of Pregnane X receptor in colon cancer cells. BMC cancer, 2011, Feb-22, Volume: 11 Topics: Azacitidine; Caco-2 Cells; Carcinoma; Cell Line, Tumor; Colonic Neoplasms; Cytochrome P-450 CYP3A; Decitabine; DNA Methylation; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; HCT116 Cells; HT29 Cells; Humans; Pregnane X Receptor; Promoter Regions, Genetic; Receptors, Calcitriol; Receptors, Steroid	2011
Down-regulation of NDRG2 gene expression in human colorectal cancer involves promoter methylation and microRNA-650. Biochemical and biophysical research communications, 2011, Mar-25, Volume: 406, Issue:4 Topics: Antimetabolites, Antineoplastic; Azacitidine; Carcinoma; Cell Line, Tumor; Colorectal Neoplasms; DNA Methylation; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Molecular Sequence Data; Promoter Regions, Genetic; Tumor Suppressor Proteins	2011
Histone deacetylase inhibitors upregulate Rap1GAP and inhibit Rap activity in thyroid tumor cells. Endocrine-related cancer, 2011, Volume: 18, Issue:3 Topics: Adenocarcinoma, Follicular; Azacitidine; Butyrates; Carcinoma; Carcinoma, Papillary; Cell Line, Tumor; Decitabine; DNA Methylation; Drug Screening Assays, Antitumor; Drug Synergism; Gene Expression Regulation, Neoplastic; GTPase-Activating Proteins; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Neoplasm Proteins; rap GTP-Binding Proteins; rap1 GTP-Binding Proteins; RNA, Small Interfering; Thyroid Neoplasms; Up-Regulation	2011
Aberrant promoter methylation in overexpression of CITED1 in papillary thyroid cancer. Thyroid : official journal of the American Thyroid Association, 2011, Volume: 21, Issue:5 Topics: Adult; Aged; Apoptosis Regulatory Proteins; Azacitidine; Carcinoma; Carcinoma, Papillary; Cell Line, Tumor; CpG Islands; Decitabine; DNA Methylation; Female; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Mutation; Nuclear Proteins; Promoter Regions, Genetic; Thyroid Cancer, Papillary; Thyroid Neoplasms; Trans-Activators; Transcription Factors	2011
DNA methyltransferase 1 as a predictive biomarker and potential therapeutic target for chemotherapy in gastric cancer. European journal of cancer (Oxford, England : 1990), 2011, Volume: 47, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Biomarkers, Tumor; Carcinoma; Cisplatin; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3B; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Male; Middle Aged; Molecular Targeted Therapy; Multivariate Analysis; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Stomach Neoplasms; Treatment Outcome; Tumor Stem Cell Assay	2011
Inhibition of p53 represses E-cadherin expression by increasing DNA methyltransferase-1 and promoter methylation in serous borderline ovarian tumor cells. Oncogene, 2011, Sep-15, Volume: 30, Issue:37 Topics: Azacitidine; Cadherins; Carcinoma; Cell Line, Tumor; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3A; DNA Methyltransferase 3B; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Neoplasm Invasiveness; Ovarian Neoplasms; Phosphatidylinositol 3-Kinases; Promoter Regions, Genetic; Proto-Oncogene Proteins c-akt; Tumor Suppressor Protein p53	2011
The DNA methylome of benign and malignant parathyroid tumors. Genes, chromosomes & cancer, 2011, Volume: 50, Issue:9 Topics: Adenoma; Azacitidine; Carcinoma; DNA Methylation; DNA Modification Methylases; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Genes, Neoplasm; Humans; Parathyroid Neoplasms; Transcription, Genetic; Tumor Cells, Cultured	2011
DNMT inhibitors and HDAC inhibitors regulate E-cadherin and Bcl-2 expression in endometrial carcinoma in vitro and in vivo. Chemotherapy, 2012, Volume: 58, Issue:1 Topics: Animals; Antineoplastic Agents; Apoptosis; Azacitidine; Cadherins; Carcinoma; Cell Cycle Checkpoints; Cell Line, Tumor; Decitabine; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Endometrial Neoplasms; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Mice; Mice, Nude; Promoter Regions, Genetic; Proto-Oncogene Proteins c-bcl-2; Transplantation, Heterologous; Valproic Acid	2012
Transcriptional silencing of the inhibin-α gene in human gastric carcinoma cells. International journal of oncology, 2012, Volume: 41, Issue:2 Topics: Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cell Survival; Decitabine; DNA Methylation; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Inhibins; Loss of Heterozygosity; Promoter Regions, Genetic; Sequence Analysis, DNA; Stomach Neoplasms; Transcription, Genetic	2012
5-aza-2'-deoxycytidine improves the sensitivity of endometrial cancer cells to progesterone therapy. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2012, Volume: 22, Issue:6 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Apoptosis; Azacitidine; Carcinoma; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Decitabine; Drug Synergism; Drug Therapy, Combination; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Neoplasm Invasiveness; Receptors, Progesterone	2012
LTBP-2 confers pleiotropic suppression and promotes dormancy in a growth factor permissive microenvironment in nasopharyngeal carcinoma. Cancer letters, 2012, Dec-01, Volume: 325, Issue:1 Topics: Azacitidine; Carcinoma; Cell Line, Tumor; Cell Movement; Cell Transformation, Neoplastic; Decitabine; DNA Methylation; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Hydroxamic Acids; Latent TGF-beta Binding Proteins; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neovascularization, Pathologic; Promoter Regions, Genetic; Tumor Microenvironment; Tumor Suppressor Proteins; Vascular Endothelial Growth Factor A	2012
Genomic methylation profiling combined with gene expression microarray reveals the aberrant methylation mechanism involved in nasopharyngeal carcinoma taxol resistance. Anti-cancer drugs, 2012, Volume: 23, Issue:8 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Azacitidine; Carcinoma; Cell Line, Tumor; Decitabine; DNA Methylation; Drug Resistance, Neoplasm; Gene Expression Profiling; Genomics; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Oligonucleotide Array Sequence Analysis; Paclitaxel	2012
5-aza-2'-deoxycytidine has minor effects on differentiation in human thyroid cancer cell lines, but modulates genes that are involved in adaptation in vitro. Thyroid : official journal of the American Thyroid Association, 2013, Volume: 23, Issue:3 Topics: Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; Carcinoma; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Survival; Decitabine; Gene Expression Regulation, Neoplastic; Humans; Hydroxamic Acids; Oligonucleotide Array Sequence Analysis; Thyroid Gland; Thyroid Neoplasms; Vorinostat	2013
DNA methylation of RUNX3 in papillary thyroid cancer. The Korean journal of internal medicine, 2012, Volume: 27, Issue:4 Topics: Azacitidine; Biomarkers, Tumor; Carcinoma; Carcinoma, Papillary; Cell Line, Tumor; Core Binding Factor Alpha 3 Subunit; Decitabine; DNA Methylation; Gene Expression; Humans; Thyroid Cancer, Papillary; Thyroid Neoplasms	2012
Detection of hypermethylated RIZ1 gene in primary tumor, mouth, and throat rinsing fluid, nasopharyngeal swab, and peripheral blood of nasopharyngeal carcinoma patient. Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Volume: 9, Issue:3 Topics: Azacitidine; Carcinoma; Case-Control Studies; Decitabine; DNA; DNA Methylation; DNA-Binding Proteins; Histone-Lysine N-Methyltransferase; Humans; Mouth; Nasopharyngeal Neoplasms; Nuclear Proteins; Pharynx; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sensitivity and Specificity; Sulfites; Transcription Factors; Transcription, Genetic; Tumor Cells, Cultured	2003
Alterations of BLU, a candidate tumor suppressor gene on chromosome 3p21.3, in human nasopharyngeal carcinoma. International journal of cancer, 2003, Aug-10, Volume: 106, Issue:1 Topics: Adult; Aged; Azacitidine; Base Sequence; Carcinoma; Chromosomes, Human, Pair 3; CpG Islands; Cytoskeletal Proteins; Decitabine; DNA Methylation; DNA Primers; Enzyme Inhibitors; Genes, Tumor Suppressor; Humans; Middle Aged; Molecular Sequence Data; Mutagens; Mutation; Nasopharyngeal Neoplasms; Polymerase Chain Reaction; Promoter Regions, Genetic; Protein Biosynthesis; Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sequence Analysis, DNA; Sulfites; Tumor Cells, Cultured; Tumor Suppressor Proteins	2003
Epigenetic inactivation of RASSF1A in head and neck cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Sep-01, Volume: 9, Issue:10 Pt 1 Topics: Azacitidine; Carcinoma; Cell Line, Tumor; Decitabine; DNA; DNA Methylation; Down-Regulation; Head and Neck Neoplasms; Humans; Microsatellite Repeats; Papillomaviridae; Point Mutation; Polymerase Chain Reaction; Promoter Regions, Genetic; Protein Isoforms; RNA; Sequence Analysis, DNA; Sulfites; Tumor Suppressor Protein p53; Tumor Suppressor Proteins	2003
Promoter methylation of cyclin D2 gene in gastric carcinoma. International journal of oncology, 2003, Volume: 23, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Carcinoma; Cell Line, Tumor; CpG Islands; Cyclin D2; Cyclins; Decitabine; DNA Methylation; Gene Expression Regulation, Neoplastic; Humans; Middle Aged; Models, Genetic; Polymerase Chain Reaction; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stomach Neoplasms	2003
Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling. Carcinogenesis, 2004, Volume: 25, Issue:5 Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Azacitidine; Carcinoma; Carcinoma, Large Cell; Case-Control Studies; Caspase 8; Caspases; Cell Adhesion Molecule-1; Cell Adhesion Molecules; Cell Cycle Proteins; Cerebellum; Child; Child, Preschool; Cohort Studies; Cyclin-Dependent Kinase Inhibitor p15; Cyclin-Dependent Kinase Inhibitor p16; Decitabine; DNA Methylation; DNA Modification Methylases; DNA-Binding Proteins; Gene Silencing; Genes, Tumor Suppressor; Histone-Lysine N-Methyltransferase; Humans; Immunoglobulins; Infant; Infant, Newborn; Kruppel-Like Transcription Factors; Medulloblastoma; Membrane Proteins; Middle Aged; Nuclear Proteins; Promoter Regions, Genetic; Proteins; Reverse Transcriptase Polymerase Chain Reaction; Tissue Inhibitor of Metalloproteinase-3; Transcription Factors; Transcription, Genetic; Tumor Cells, Cultured; Tumor Protein p73; Tumor Suppressor Protein p14ARF; Tumor Suppressor Proteins	2004
Human PinX1, a potent telomerase inhibitor, is not involved in human gastrointestinal tract carcinoma. Oncology reports, 2004, Volume: 11, Issue:4 Topics: Azacitidine; Carcinoma; Cell Cycle Proteins; Cell Line, Tumor; CpG Islands; Decitabine; DNA Methylation; Gastrointestinal Neoplasms; Gene Expression; Humans; Mutation, Missense; Polymorphism, Genetic; Promoter Regions, Genetic; RNA, Messenger; Sequence Analysis, DNA; Telomerase; Tumor Suppressor Proteins	2004
The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma. Oncogene, 2004, Jun-10, Volume: 23, Issue:27 Topics: Alleles; Animals; Azacitidine; Base Sequence; Carcinoma; Cell Line; Cell Line, Tumor; Cell Transformation, Viral; Chromosomes, Human, Pair 3; CpG Islands; Decitabine; DNA Methylation; Enzyme Inhibitors; Epigenesis, Genetic; Gene Deletion; Gene Expression Regulation, Neoplastic; Gene Silencing; Genes, Tumor Suppressor; Humans; Mice; Mice, Nude; Molecular Sequence Data; Nasopharyngeal Neoplasms; Promoter Regions, Genetic; Protein Binding; Stress, Physiological; Tumor Suppressor Proteins	2004
Chemically induced DNA hypomethylation in breast carcinoma cells detected by the amplification of intermethylated sites. Breast cancer research : BCR, 2004, Volume: 6, Issue:4 Topics: Azacitidine; Breast Neoplasms; Carcinoma; Cell Line, Tumor; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA, Neoplasm; Humans; Nucleic Acid Amplification Techniques; Promoter Regions, Genetic	2004
Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis. Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Nov-15, Volume: 10, Issue:22 Topics: Adult; Aged; Aged, 80 and over; Azacitidine; Carcinoma; Cell Differentiation; Cell Line, Tumor; Colon; Colorectal Neoplasms; Disease Progression; DNA Methylation; DNA Primers; DNA-Binding Proteins; Female; Humans; Immunohistochemistry; Inhibitor of Differentiation Protein 2; Male; Middle Aged; Models, Genetic; Neoplasms; Polymerase Chain Reaction; Prognosis; Repressor Proteins; Risk; RNA, Messenger; Sequence Analysis, DNA; Sulfites; Time Factors; Transcription Factors	2004
Methylation of the CA9 promoter can modulate expression of the tumor-associated carbonic anhydrase IX in dense carcinoma cell lines. International journal of oncology, 2005, Volume: 26, Issue:4 Topics: Antigens, Neoplasm; Antimetabolites, Antineoplastic; Azacitidine; Biomarkers, Tumor; Carbonic Anhydrase IX; Carbonic Anhydrases; Carcinoma; Carcinoma, Renal Cell; Colonic Neoplasms; Decitabine; DNA Methylation; Female; Fibroblasts; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Isoenzymes; Kidney Neoplasms; Promoter Regions, Genetic; Tumor Cells, Cultured; Uterine Cervical Neoplasms	2005
Loss of caspase-1 gene expression in human gastric carcinomas and cell lines. International journal of oncology, 2005, Volume: 26, Issue:5 Topics: Antimetabolites, Antineoplastic; Azacitidine; Carcinoma; Caspase 1; Decitabine; DNA Methylation; Female; Gene Expression Profiling; Histones; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Prognosis; Stomach Neoplasms; Survival Analysis; Tumor Cells, Cultured	2005
Expression and methylation pattern of TSLC1 cascade genes in lung carcinomas. Oncogene, 2006, Feb-09, Volume: 25, Issue:6 Topics: Antimetabolites, Antineoplastic; Azacitidine; Carcinoma; Carcinoma, Non-Small-Cell Lung; Cell Adhesion Molecule-1; Cell Adhesion Molecules; Decitabine; DNA Methylation; Gene Expression Regulation, Neoplastic; Humans; Immunoglobulins; Lung Neoplasms; Membrane Proteins; Microfilament Proteins; Nuclear Proteins; Oligonucleotide Array Sequence Analysis; Transcription Factors; Tumor Cells, Cultured; Tumor Suppressor Proteins	2006
Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation. Oncogene, 2006, Feb-16, Volume: 25, Issue:7 Topics: Azacitidine; Cadherins; Carcinoma; Cell Movement; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3B; Epigenesis, Genetic; Esophageal Neoplasms; Gene Silencing; Genes, Tumor Suppressor; Humans; Nasopharyngeal Neoplasms; Promoter Regions, Genetic; Protocadherins; Sequence Deletion; Transcription, Genetic	2006
Wnt signaling activation and WIF-1 silencing in nasopharyngeal cancer cell lines. Biochemical and biophysical research communications, 2006, Mar-10, Volume: 341, Issue:2 Topics: Adaptor Proteins, Signal Transducing; Azacitidine; Blotting, Western; Carcinoma; Carrier Proteins; Cell Line, Tumor; Decitabine; DNA Methylation; DNA, Complementary; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Nasopharyngeal Neoplasms; Promoter Regions, Genetic; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Sequence Analysis, DNA; Signal Transduction; Transfection; Wnt Proteins	2006
Nickel ions increase histone H3 lysine 9 dimethylation and induce transgene silencing. Molecular and cellular biology, 2006, Volume: 26, Issue:10 Topics: Animals; Azacitidine; Blotting, Western; Carcinoma; Cell Line; Cell Line, Tumor; Cell Survival; Chromatin Immunoprecipitation; Decitabine; DNA Methylation; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Epigenesis, Genetic; Fibroblasts; Gene Silencing; Histones; Humans; Kinetics; Lung Neoplasms; Lysine; Methyltransferases; Mice; Nickel; Trace Elements; Transgenes	2006
RIZ1 is epigenetically inactivated by promoter hypermethylation in thyroid carcinoma. Cancer, 2006, Dec-15, Volume: 107, Issue:12 Topics: Antimetabolites, Antineoplastic; Azacitidine; Carcinoma; Cell Line, Tumor; DNA Methylation; DNA-Binding Proteins; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Histone-Lysine N-Methyltransferase; Humans; Nuclear Proteins; Promoter Regions, Genetic; RNA, Messenger; Thyroid Neoplasms; Transcription Factors	2006
Downregulation of TSLC1 and DAL-1 expression occurs frequently in breast cancer. Breast cancer research and treatment, 2007, Volume: 103, Issue:3 Topics: Azacitidine; Breast Neoplasms; Carcinoma; Cell Adhesion; Cell Adhesion Molecule-1; Cell Adhesion Molecules; Cell Line, Tumor; Decitabine; DNA Methylation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Immunoglobulins; Membrane Proteins; Microfilament Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA; Sulfites; Tumor Suppressor Proteins	2007
The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas. Laboratory investigation; a journal of technical methods and pathology, 2007, Volume: 87, Issue:7 Topics: Adaptor Proteins, Signal Transducing; Animals; Azacitidine; Biomarkers, Tumor; Carcinoma; Cell Line; Cell Line, Tumor; Cell Proliferation; Decitabine; DNA Methylation; Down-Regulation; Esophageal Neoplasms; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Nasopharyngeal Neoplasms; Promoter Regions, Genetic; Repressor Proteins; Tumor Suppressor Proteins; Wnt1 Protein	2007
Genetic and epigenetic alterations of LTF at 3p21.3 in nasopharyngeal carcinoma. Oncology research, 2006, Volume: 16, Issue:6 Topics: Azacitidine; Base Sequence; Carcinoma; Cell Line, Tumor; Chromosomes, Human, Pair 3; CpG Islands; Decitabine; DNA Methylation; DNA Modification Methylases; DNA Mutational Analysis; Down-Regulation; Enzyme Inhibitors; Epigenesis, Genetic; Exons; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Lactoferrin; Loss of Heterozygosity; Male; Middle Aged; Molecular Sequence Data; Mutation; Nasopharyngeal Neoplasms; Polymorphism, Single-Stranded Conformational; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger	2006
The N-methyl-D-aspartate receptor type 2A is frequently methylated in human colorectal carcinoma and suppresses cell growth. Oncogene, 2008, Mar-27, Volume: 27, Issue:14 Topics: Azacitidine; Carcinoma; Cell Proliferation; Colorectal Neoplasms; Decitabine; DNA Methylation; DNA Modification Methylases; Humans; Immunohistochemistry; Promoter Regions, Genetic; Receptors, N-Methyl-D-Aspartate; Tissue Array Analysis	2008
Clinical significance of the reduced expression of G protein gamma 7 (GNG7) in oesophageal cancer. British journal of cancer, 2008, Jan-29, Volume: 98, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Carcinoma; Cell Line, Tumor; Chromosomes, Human, Pair 19; DNA Methylation; Down-Regulation; Esophageal Neoplasms; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; GTP-Binding Protein gamma Subunits; Humans; Loss of Heterozygosity; Male; MicroRNAs; Middle Aged; Neoplasm Invasiveness; Prognosis; RNA, Messenger	2008
Deleterious CHEK2 1100delC and L303X mutants identified among 38 human breast cancer cell lines. Breast cancer research and treatment, 2009, Volume: 113, Issue:2 Topics: Azacitidine; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Checkpoint Kinase 2; Codon, Nonsense; Colorectal Neoplasms; DNA Methylation; DNA Mutational Analysis; DNA, Neoplasm; Female; G1 Phase; Gene Expression Regulation, Neoplastic; Genes, cdc; Genes, p53; Humans; Male; Neoplasm Proteins; Polymorphism, Single Nucleotide; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Tumor Suppressor Protein p53	2009
Persistent downregulation of the pancarcinoma-associated epithelial cell adhesion molecule via active intranuclear methylation. International journal of cancer, 2008, Jul-15, Volume: 123, Issue:2 Topics: Antigens, Neoplasm; Antineoplastic Agents; Azacitidine; Carcinoma; Cell Adhesion Molecules; Cell Line, Tumor; Cell Nucleus; DNA Methylation; DNA-Cytosine Methylases; Down-Regulation; Epithelial Cell Adhesion Molecule; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Ovarian Neoplasms; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Time Factors; Transcription, Genetic; Up-Regulation	2008
Sequential combination of pyrazofurin and 5-azacytidine in patients with acute myelocytic leukemia and carcinoma. Oncology, 1981, Volume: 38, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Amides; Azacitidine; Carcinoma; Carcinoma, Small Cell; Drug Therapy, Combination; Female; Humans; Leukemia, Myeloid; Lung Neoplasms; Male; Middle Aged; Pyrazoles; Ribonucleosides; Ribose	1981
Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proceedings of the National Academy of Sciences of the United States of America, 1995, Aug-01, Volume: 92, Issue:16 Topics: Azacitidine; Base Sequence; Cadherins; Carcinoma; DNA Primers; DNA, Neoplasm; Gene Expression; Genes, Regulator; Genes, Tumor Suppressor; Humans; Methylation; Molecular Sequence Data; Neoplasm Invasiveness; Oligodeoxyribonucleotides; Promoter Regions, Genetic; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured	1995
Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression. Cancer research, 1999, May-01, Volume: 59, Issue:9 Topics: Adaptor Proteins, Signal Transducing; Azacitidine; Base Pair Mismatch; Carcinoma; Carrier Proteins; Colorectal Neoplasms; Colorectal Neoplasms, Hereditary Nonpolyposis; CpG Islands; Decitabine; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Mutational Analysis; DNA Repair; DNA, Neoplasm; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Humans; Microsatellite Repeats; MutL Protein Homolog 1; Neoplasm Proteins; Nuclear Proteins; Promoter Regions, Genetic; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured	1999
Transcriptional silencing of Cyclooxygenase-2 by hyper-methylation of the 5' CpG island in human gastric carcinoma cells. Cancer research, 2001, Jun-01, Volume: 61, Issue:11 Topics: Azacitidine; Blotting, Southern; Carcinoma; Chromosome Mapping; CpG Islands; Cyclooxygenase 2; Decitabine; DNA Methylation; Enzyme Induction; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Isoenzymes; Membrane Proteins; Promoter Regions, Genetic; Prostaglandin-Endoperoxide Synthases; Stomach Neoplasms; Transcription, Genetic; Tumor Cells, Cultured	2001
Promoter hypermethylation of MGMT is associated with protein loss in gastric carcinoma. International journal of cancer, 2001, Volume: 93, Issue:6 Topics: Alleles; Antimetabolites, Antineoplastic; Azacitidine; Blotting, Western; Carcinoma; CpG Islands; Decitabine; DNA Methylation; Enzyme Inhibitors; Genes, p53; Humans; Mutation; O(6)-Methylguanine-DNA Methyltransferase; Polymorphism, Single-Stranded Conformational; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Stomach Neoplasms; Transcription, Genetic; Tumor Cells, Cultured	2001
E-cadherin expression is commonly downregulated by CpG island hypermethylation in esophageal carcinoma cells. Cancer letters, 2001, Nov-08, Volume: 173, Issue:1 Topics: Azacitidine; Cadherins; Carcinoma; CpG Islands; Decitabine; DNA Methylation; DNA Modification Methylases; Down-Regulation; Enzyme Inhibitors; Esophageal Neoplasms; Humans; Promoter Regions, Genetic; RNA, Neoplasm; Transcription, Genetic; Tumor Cells, Cultured	2001
Expression of the Hypermethylated in Cancer gene (HIC-1) is associated with good outcome in human breast cancer. British journal of cancer, 2001, Dec-14, Volume: 85, Issue:12 Topics: Antimetabolites, Antineoplastic; Azacitidine; Breast Neoplasms; Carcinoma; Chromosome Deletion; Chromosomes, Human, Pair 17; Cohort Studies; Decitabine; DNA Methylation; Enzyme Inhibitors; Female; Follow-Up Studies; Gene Deletion; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Silencing; Genes, p53; Humans; Kruppel-Like Transcription Factors; Loss of Heterozygosity; Neoplasm Proteins; Prognosis; Prospective Studies; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Survival Analysis; Transcription Factors; Tumor Cells, Cultured	2001
Lack of IFN-gamma-mediated induction of the class II transactivator (CIITA) through promoter methylation is predominantly found in developmental tumor cell lines. International journal of cancer, 2002, Feb-01, Volume: 97, Issue:4 Topics: Azacitidine; Burkitt Lymphoma; Carcinoma; Cell Differentiation; CpG Islands; DNA Methylation; Gene Expression Regulation, Developmental; Gene Expression Regulation, Neoplastic; Gene Silencing; Genes, MHC Class II; Genes, Reporter; HLA-DR Antigens; Humans; Interferon-gamma; Melanoma; Neoplasm Proteins; Nuclear Proteins; Promoter Regions, Genetic; Signal Transduction; Trans-Activators; Transfection; Tumor Cells, Cultured	2002
Tumour specific promoter region methylation of the human homologue of the Drosophila Roundabout gene DUTT1 (ROBO1) in human cancers. Oncogene, 2002, May-02, Volume: 21, Issue:19 Topics: Animals; Azacitidine; Breast Neoplasms; Carcinoma; Carcinoma, Non-Small-Cell Lung; Chromosomes, Human, Pair 3; CpG Islands; Decitabine; DNA Methylation; DNA Mutational Analysis; DNA, Neoplasm; Drosophila melanogaster; Drosophila Proteins; Female; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Kidney Neoplasms; Loss of Heterozygosity; Lung Neoplasms; Mutation, Missense; Nerve Tissue Proteins; Promoter Regions, Genetic; Receptors, Immunologic; Roundabout Proteins; Sequence Homology, Nucleic Acid; Tumor Cells, Cultured	2002
Inactivation of O6-methylguanine-DNA methyltransferase by promoter CpG island hypermethylation in gastric cancers. British journal of cancer, 2002, Jun-17, Volume: 86, Issue:12 Topics: Antimetabolites, Antineoplastic; Azacitidine; Carcinoma; CpG Islands; Decitabine; DNA Methylation; DNA Modification Methylases; DNA Primers; Down-Regulation; Enzyme Inhibitors; Humans; Microsatellite Repeats; Mutation; Neoplasm Invasiveness; Neoplasm Staging; O(6)-Methylguanine-DNA Methyltransferase; Prognosis; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sequence Analysis, DNA; Stomach; Stomach Neoplasms; Sulfites; Survival Rate; Transcription, Genetic; Tumor Cells, Cultured	2002
Phase II study of 5-aza-2'-deoxycytidine in advanced ovarian carcinoma. The EORTC Early Clinical Trials Group. European journal of cancer (Oxford, England : 1990), 1990, Volume: 26, Issue:2 Topics: Adult; Aged; Antineoplastic Agents; Azacitidine; Carcinoma; Decitabine; Drug Evaluation; Female; Humans; Middle Aged; Ovarian Neoplasms	1990